コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 g for CFR, the effect of sex on outcomes was no longer significant.
2 99% of the group effect was explained and is no longer significant.
3 lation, but at 72 hrs these differences were no longer significant.
4 iation between TIMI bleeding and outcome was no longer significant.
5 these between-group effects were similar but no longer significant.
6 e SDF1-3'A allele on disease progression was no longer significant.
7 1), whereas the time period of diagnosis was no longer significant.
8 as a percent of daily totals, "cardiac" was no longer significant.
9 When stratified by PAD, this trend was no longer significant.
10 in ASCOT-BPLA, but residual differences were no longer significant.
11 f death for infants born on the weekend were no longer significant.
12 was adjusted for dose/mass, age effects were no longer significant.
13 type 2 diabetes was attenuated and the trend no longer significant.
14 age and weight, the differences in BUA were no longer significant.
15 onse well beyond the time hu5C8 effects were no longer significant.
16 tance, marital status, and reproduction were no longer significant.
17 py, the observed benefit of primary PTCA was no longer significant.
18 rence in infection rates analyzed by sex was no longer significant.
19 9; p <0.001), whereas the effect of LVEF was no longer significant.
20 e 2 groups, the differences in outcomes were no longer significant.
21 After T2, differences between groups were no longer significant.
22 cident CVD and cardiovascular mortality were no longer significant.
23 in group; at 30 days, these differences were no longer significant.
24 adjusted for adiposity, the differences were no longer significant.
25 tion between BMI and operative mortality was no longer significant.
26 biomarkers were substantially attenuated and no longer significant.
27 g for multiple subgroups, those results were no longer significant.
28 differences among groups were attenuated and no longer significant.
29 ion frequency and radiological severity were no longer significant.
30 n treatment status, these relationships were no longer significant.
31 ion of race with longer time for listing was no longer significant.
32 ficant, whereas the association for SFAs was no longer significant.
33 ed, except the association with epilepsy was no longer significant.
34 ssociation of tofu with immediate recall was no longer significant.
35 differences in survival between groups were no longer significant.
36 e difference in TTP between the two arms was no longer significant.
37 25(OH)D and cardiovascular risk factors were no longer significant.
38 eographic distance, but that relationship is no longer significant.
39 ring PEPFAR's activities, the difference was no longer significant.
40 hen controlling for age, the association was no longer significant.
41 w factors were identified whereas others are no longer significant.
42 FH and unaffected siblings after 2 years was no longer significant (0.408+/-0.043 and 0.402+/-0.042 m
43 mortality in the participating hospitals was no longer significant (-0.1 percentage points; 95% CI, -
44 0003), but by final follow-up the excess was no longer significant (679/3548 [19.1%] vs 640/3464 [18.
45 low-up, the difference in response rates was no longer significant (69 percent vs. 25 percent, P=0.08
47 nary artery calcium with type 2 diabetes was no longer significant after adding body mass index to th
48 ated with incident CHF, this association was no longer significant after adding inflammatory markers
49 fidence interval [CI]: 1.15 to 1.72) but was no longer significant after adjusting for behavioral mec
51 1.75; 95% CI, 1.04-2.94), although this was no longer significant after adjusting for changes in dis
52 oup (2.2%, 1.2%, 0.8%; p < 0.001), which was no longer significant after adjusting for confounding va
53 although these additional associations were no longer significant after adjusting for delayed episod
55 ) on the overdispersion rate was notable but no longer significant after adjusting the effect from se
58 between statin or aspirin use with IOP were no longer significant after adjustment for beta-blocker
59 ilon3 group, the genotype effect on risk was no longer significant after adjustment for classic risk
60 osite score: independent of age and sex, but no longer significant after adjustment for education.
61 Sbeta(0) adults, but these associations were no longer significant after adjustment for hemoglobin le
62 isk of birth defects associated with IVF was no longer significant after adjustment for parental fact
64 ], respectively), but these differences were no longer significant after allowing for sex and body si
65 over placebo in antidepressant efficacy was no longer significant after controlling for change in ne
66 = .01); but its advantage on neuroticism was no longer significant after controlling for depression (
67 ssociated with exposure during pregnancy was no longer significant after controlling for maternal maj
68 osure to organochlorines and metals but were no longer significant after controlling for sociodemogra
69 es (P < 0.001); however, this difference was no longer significant after controlling for subject-spec
70 h end-tidal alveolar dead space fraction was no longer significant after controlling for the combinat
71 h end-tidal alveolar dead space fraction was no longer significant after controlling for the combinat
72 375 mL, respectively; P<0.001), but this was no longer significant after correction for diuretic dose
73 ifferences in femoral artery blood flow were no longer significant after correction for estimated leg
74 n flux in the winter, but these signals were no longer significant after correction for multiple test
75 ted differences in femoral hemodynamics were no longer significant after correction for the influence
77 African Americans (27.8%, p < 0.05) but was no longer significant after further adjustment for body
78 tive hazard, 0.71; P = .02), although it was no longer significant after further adjustment for curre
79 sity measures to coronary artery calcium was no longer significant after inclusion of apolipoprotein
80 significant in sequenced participants, were no longer significant after multiple testing corrections
81 idence interval, 1.96.4.0; P<0.0001) but was no longer significant after multivariable adjustment.
82 between GV and mortality for each metric was no longer significant after multivariable adjustment.
83 e interval, 1.1 to 5.5), the association was no longer significant after multivariable adjustment.
84 ause readmission, but these differences were no longer significant after risk adjustment on 30-day (h
85 ociation of GFR with all-cause mortality was no longer significant after the addition of the filtrati
86 rates decreased with increasing age and was no longer significant after the age of 74 (P< 0.001 for
87 in converters were markedly attenuated (and no longer significant) after adjustment for the homeosta
88 tric slopes for marsupials and eutherians is no longer significant and the slope difference between S
89 at did not receive VC, area differences were no longer significant as all values trended towards zero
90 G and PTCA in costs and quality of life were no longer significant at 10 to 12 years of follow-up.
91 m for DL versus 0.17 mm for IL; P <0.05) was no longer significant at 2 months (0 versus 0.08 mm for
94 of asthma between ELBW and NBW children were no longer significant at the age of 14 years (23% vs 17%
95 ing over time such that the relationship was no longer significant by approximately 5 months after AC
96 haemodynamic associations were attenuated or no longer significant, consistent with the hypothesis th
97 blication bias was accounted for, there were no longer significant differences in adherence between a
99 ke, all intergroup differences for beer were no longer significant; differences for other alcohol sou
101 which were found in the previous study, were no longer significant even when the groups were combined
102 s of age, the between-group differences were no longer significant for autoimmunity (21% in group A a
103 atus, and comorbidities, the association was no longer significant for Hispanics (OR, 0.95; 95% CI, 0
106 se factors, difference in survival rates was no longer significant (hazard ratio 0.90 for the second
107 ferences between groups, the association was no longer significant (hazard ratio 0.99; 95% CI 0.77-1.
108 d with MetS was substantially attenuated and no longer significant (hazard ratio 1.14, 95% confidence
109 r multivariate analysis, this difference was no longer significant (HR 1.41; 95% CI 0.88 to 2.27).
110 y measures to the model, the association was no longer significant (HR, 1.10; 95% CI, 0.96-1.26).
111 of BRAF V600E with mortality for all PTC was no longer significant (HR, 1.21; 95% CI, 0.53-2.76).
114 ficacy of cell therapy on all end points was no longer significant in placebo-controlled randomized c
115 ity and vascular involvement, ulceration was no longer significant in predicting overall survival.
117 parkinsonism was attenuated by >60% and was no longer significant (Lewy bodies: estimate, 0.112; SE,
118 using a random-effects model, the effect was no longer significant (odds ratio, 0.65; 95% CI, 0.25-1.
119 rtant in the cutaneous stages of disease are no longer significant once extracutaneous disease develo
120 t loss because of rejection, this effect was no longer significant once its association with the stro
121 ity at 2 years was evident, this finding was no longer significant once surgeon-specific volume was c
122 sted breast cancer models, associations were no longer significant (OR = 1.06, 95% CI: 0.78, 1.43).
123 perative cholangiography and duct injury was no longer significant (OR, 1.26 [95% CI, 0.81-1.96]; P =
124 es (range FST 0.001-0.019, Nm 12.7-226.1) or no longer significant (P > 0.05) in the case of RST.
127 um triglycerides, and BMI (P = 0.02) but was no longer significant (P = 0.1) after adjustment for bas
130 his compound were removed, heterogeneity was no longer significant (P =.58), and the pooled effect si
132 Differences in alveolar bone levels were no longer significant, particularly after introducing th
133 r, risk for subjective memory impairment was no longer significant (RR [95% CI]: 1.18 [0.95-1.47], p
134 ychological scores at baseline, results were no longer significant (RR: 1.09; 95% CI: 0.99, 1.21; P-t
135 e slope of the relation between PK and U was no longer significant, so that PK was no longer flow dep
136 operator volume and in-hospital mortality is no longer significant, the relationship between volume a
137 =0.06), the relative risk for graft loss was no longer significant when additionally adjusted for ind
141 were attenuated and, for common carotid IMT, no longer significant when lipids, hypertension, diabete
142 ed for primary tumor size (P = 0.03) but was no longer significant when stratified for disease status
144 erences in REE were reduced by >50% and were no longer significant when the mass of specific high-met
145 in concentrations and neutrophil counts were no longer significant, whereas differences in platelet,
146 ler magnitude than in the overall cohort and no longer significant, whereas in the ROW subgroup, the
147 nd comorbidities however, the difference was no longer significant with an odds ratio of 1.11 (95% co
149 effect of micrometastases decreased and was no longer significant, with a hazard ratio of 1.09 (0.74
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。